CARD9


Journal

Nature immunology
ISSN: 1529-2916
Titre abrégé: Nat Immunol
Pays: United States
ID NLM: 100941354

Informations de publication

Date de publication:
05 2019
Historique:
received: 25 05 2018
accepted: 12 03 2019
entrez: 19 4 2019
pubmed: 19 4 2019
medline: 30 4 2019
Statut: ppublish

Résumé

The C-type lectin receptor-Syk (spleen tyrosine kinase) adaptor CARD9 facilitates protective antifungal immunity within the central nervous system (CNS), as human deficiency in CARD9 causes susceptibility to fungus-specific, CNS-targeted infection. CARD9 promotes the recruitment of neutrophils to the fungus-infected CNS, which mediates fungal clearance. In the present study we investigated host and pathogen factors that promote protective neutrophil recruitment during invasion of the CNS by Candida albicans. The cytokine IL-1β served an essential function in CNS antifungal immunity by driving production of the chemokine CXCL1, which recruited neutrophils expressing the chemokine receptor CXCR2. Neutrophil-recruiting production of IL-1β and CXCL1 was induced in microglia by the fungus-secreted toxin Candidalysin, in a manner dependent on the kinase p38 and the transcription factor c-Fos. Notably, microglia relied on CARD9 for production of IL-1β, via both transcriptional regulation of Il1b and inflammasome activation, and of CXCL1 in the fungus-infected CNS. Microglia-specific Card9 deletion impaired the production of IL-1β and CXCL1 and neutrophil recruitment, and increased fungal proliferation in the CNS. Thus, an intricate network of host-pathogen interactions promotes antifungal immunity in the CNS; this is impaired in human deficiency in CARD9, which leads to fungal disease of the CNS.

Identifiants

pubmed: 30996332
doi: 10.1038/s41590-019-0377-2
pii: 10.1038/s41590-019-0377-2
pmc: PMC6494474
mid: NIHMS1523856
doi:

Substances chimiques

CARD Signaling Adaptor Proteins 0
Card9 protein, mouse 0
Chemokine CXCL1 0
Cxcl1 protein, mouse 0
Cytokines 0
Inflammasomes 0
Interleukin-1beta 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

559-570

Subventions

Organisme : NIDCR NIH HHS
ID : R01 DE026600
Pays : United States
Organisme : NIAID NIH HHS
ID : R37 AI093808
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA161373
Pays : United States
Organisme : NIH HHS
ID : R01AI124566
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : Medical Research Council
ID : MR/N006364/1
Pays : United Kingdom
Organisme : NIH HHS
ID : R01 093808
Pays : United States
Organisme : NIH HHS
ID : R01CA161373
Pays : United States
Organisme : Medical Research Council
ID : MR/N006364/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M011372/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 102705/Z/13/Z
Pays : United Kingdom
Organisme : NIDDK NIH HHS
ID : R01 DK110352
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI124566
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA AI001175-01
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE017088
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Lionakis, M. S. & Levitz, S. M. Host control of fungal infections: lessons from basic studies and human cohorts. Annu. Rev. Immunol. 36, 157–191 (2018).
doi: 10.1146/annurev-immunol-042617-053318
Drummond, R. A. & Lionakis, M. S. Mechanistic insights into the role of C-type lectin receptor/CARD9 signaling in human antifungal immunity. Front. Cell Infect. Microbiol. 6, 39 (2016).
doi: 10.3389/fcimb.2016.00039
Glocker, E. O. et al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N. Engl. J. Med. 361, 1727–1735 (2009).
doi: 10.1056/NEJMoa0810719
Lanternier, F. et al. Deep dermatophytosis and inherited CARD9 deficiency. N. Engl. J. Med. 369, 1704–1714 (2013).
doi: 10.1056/NEJMoa1208487
Drummond, R. A. et al. CARD9-dependent neutrophil recruitment protects against fungal invasion of the central nervous system. PLoS Pathog. 11, e1005293 (2015).
doi: 10.1371/journal.ppat.1005293
Li, X. et al. The β-glucan receptor Dectin-1 activates the integrin Mac-1 in neutrophils via Vav protein signaling to promote Candida albicans clearance. Cell Host Microbe 10, 603–615 (2011).
doi: 10.1016/j.chom.2011.10.009
Drewniak, A. et al. Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency. Blood 121, 2385–2392 (2013).
doi: 10.1182/blood-2012-08-450551
Altmeier, S. et al. IL-1 coordinates the neutrophil response to C. albicans in the oral mucosa. PLOS Pathog. 12, e1005882 (2016).
doi: 10.1371/journal.ppat.1005882
Karki, R. et al. Concerted activation of the AIM2 and NLRP3 inflammasomes orchestrates host protection against Aspergillus infection. Cell Host Microbe 17, 357–368 (2015).
doi: 10.1016/j.chom.2015.01.006
Biondo, C. et al. The interleukin-1β/CXCL1/2/neutrophil axis mediates host protection against group B streptococcal infection. Infect. Immun. 82, 4508–4517 (2014).
doi: 10.1128/IAI.02104-14
Nemeth, T., Futosi, K., Sitaru, C., Ruland, J. & Mocsai, A. Neutrophil-specific deletion of the CARD9 gene expression regulator suppresses autoantibody-induced inflammation in vivo. Nat. Commun. 7, 11004 (2016).
doi: 10.1038/ncomms11004
Wang, X. et al. Impaired specific antifungal immunity in CARD9-deficient patients with phaeohyphomycosis. J. Invest. Dermatol. 138, 607–617 (2018).
doi: 10.1016/j.jid.2017.10.009
Lionakis, M. S. et al. Chemokine receptor Ccr1 drives neutrophil-mediated kidney immunopathology and mortality in invasive candidiasis. PLoS Pathog. 8, e1002865 (2012).
doi: 10.1371/journal.ppat.1002865
Lee, E. K. S. et al. Leukotriene B4-mediated neutrophil recruitment causes pulmonary capillaritis during lethal fungal sepsis. Cell Host Microbe 23, 121–133.e124 (2018).
doi: 10.1016/j.chom.2017.11.009
Swamydas, M. et al. CXCR1-mediated neutrophil degranulation and fungal killing promote Candida clearance and host survival. Sci. Trans. Med. 8, 322ra310–322ra310 (2016).
doi: 10.1126/scitranslmed.aac7718
Ngo, L. Y. et al. Inflammatory monocytes mediate early and organ-specific innate defense during systemic candidiasis. J. Infect. Dis. 209, 109–119 (2014).
doi: 10.1093/infdis/jit413
Erwig, L. P. & Gow, N. A. R. Interactions of fungal pathogens with phagocytes. Nat. Rev. Microbiol. 14, 163–176 (2016).
doi: 10.1038/nrmicro.2015.21
Zheng, X., Wang, Y. & Wang, Y. Hgc1, a novel hypha-specific G1 cyclin-related protein regulates Candida albicans hyphal morphogenesis. EMBO J. 23, 1845–1856 (2004).
doi: 10.1038/sj.emboj.7600195
Moyes, D. L. et al. Candidalysin is a fungal peptide toxin critical for mucosal infection. Nature 532, 64–68 (2016).
doi: 10.1038/nature17625
Verma, A. H. et al. Oral epithelial cells orchestrate innate type 17 responses to Candida albicans through the virulence factor candidalysin. Sci. Immunol. 2, eaam8834 (2017).
doi: 10.1126/sciimmunol.aam8834
Richardson, J. P. et al. Candidalysin drives epithelial signaling, neutrophil recruitment, and immunopathology at the vaginal mucosa. Infect. Immun. 86, e00645–17 (2017).
doi: 10.1128/IAI.00645-17
Naglik, J. R., Challacombe, S. J. & Hube, B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol. Mol. Biol. Rev. 67, 400–428 (2003).
doi: 10.1128/MMBR.67.3.400-428.2003
Gabrielli, E. et al. In vivo induction of neutrophil chemotaxis by secretory aspartyl proteinases of Candida albicans. Virulence 7, 819–825 (2016).
doi: 10.1080/21505594.2016.1184385
Pericolini, E. et al. Secretory aspartyl proteinases cause vaginitis and can mediate vaginitis caused by Candida albicans in mice. mBio 6, e00724–15 (2015).
doi: 10.1128/mBio.00724-15
Henn, A. et al. The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. Altex-Alternativen Zu Tierexperimenten 26, 83–94 (2009).
Hennessy, E., Griffin, É. W. & Cunningham, C. Astrocytes are primed by chronic neurodegeneration to produce exaggerated chemokine and cell infiltration responses to acute stimulation with the cytokines IL-1β and TNF-α. J. Neurosci 35, 8411–8422 (2015).
doi: 10.1523/JNEUROSCI.2745-14.2015
Pineau, I., Sun, L., Bastien, D. & Lacroix, S. Astrocytes initiate inflammation in the injured mouse spinal cord by promoting the entry of neutrophils and inflammatory monocytes in an IL-1 receptor/MyD88-dependent fashion. Brain Behav. Immun. 24, 540–553 (2010).
doi: 10.1016/j.bbi.2009.11.007
Omari, K. M., John, G., Lango, R. & Raine, C. S. Role for CXCR2 and CXCL1 on glia in multiple sclerosis. Glia 53, 24–31 (2005).
doi: 10.1002/glia.20246
Poeck, H. et al. Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1β production. Nat. Immunol. 11, 63–69 (2009).
doi: 10.1038/ni.1824
Pereira, M., Tourlomousis, P., Wright, J., P Monie, T. & Bryant, C. E. CARD9 negatively regulates NLRP3-induced IL-1β production on Salmonella infection of macrophages. Nat. Commun. 7, 12874–12874 (2016).
doi: 10.1038/ncomms12874
Kasper, L. et al. The fungal peptide toxin Candidalysin activates the NLRP3 inflammasome and causes cytolysis in mononuclear phagocytes. Nat. Commun. 9, 4260 (2018).
doi: 10.1038/s41467-018-06607-1
Parkhurst, C. N. et al. Microglia promote learning-dependent synapse formation through BDNF. Cell 155, 1596–1609 (2013).
doi: 10.1016/j.cell.2013.11.030
Pappas, P. G., Lionakis, M. S., Arendrup, M. C., Ostrosky-Zeichner, L. & Kullberg, B. J. Invasive candidiasis. Nat. Rev. Dis. Primers 4, 18026 (2018).
doi: 10.1038/nrdp.2018.26
Lionakis, M. S., Netea, M. G. & Holland, S. M. Mendelian genetics of human susceptibility to fungal infection. Cold Spring Harbor Perspect. Med. 4, a019638 (2014).
doi: 10.1101/cshperspect.a019638
McCarthy, M. W., Kalasauskas, D., Petraitis, V., Petraitiene, R. & Walsh, T. J. Fungal infections of the central nervous system in children. J. Pediatr. Infect. Dis. Soc. 6, e123–e133 (2017).
Drummond, R. A. & Lionakis, M. S. Candidiasis of the central nervous system in neonates and children with primary immunodeficiencies. Curr. Fungal Infect. Rep. 12, 92–97 (2018).
doi: 10.1007/s12281-018-0316-y
Cetinkaya, P. G. et al. A young girl with severe cerebral fungal infection due to card 9 deficiency. Clin. Immunol. 191, 21–26 (2018).
doi: 10.1016/j.clim.2018.01.002
Lanternier, F. et al. Inherited CARD9 deficiency in otherwise healthy children and adults with Candida species-induced meningoencephalitis, colitis, or both. J. Allergy Clin. Immunol. 135, 1558–1568 (2015).
doi: 10.1016/j.jaci.2014.12.1930
Del Rio, L., Bennouna, S., Salinas, J. & Denkers, E. Y. CXCR2 deficiency confers impaired neutrophil recruitment and increased susceptibility during Toxoplasma gondii infection. J. Immunol. 167, 6503–6509 (2001).
doi: 10.4049/jimmunol.167.11.6503
Bonnett, C. R., Cornish, E. J., Harmsen, A. G. & Burritt, J. B. Early neutrophil recruitment and aggregation in the murine lung inhibit germination of Aspergillus fumigatus conidia. Infect. Immun. 74, 6528–6539 (2006).
doi: 10.1128/IAI.00909-06
Lévesque, S. A. et al. Myeloid cell transmigration across the CNS vasculature triggers IL-1β-driven neuroinflammation during autoimmune encephalomyelitis in mice. J. Exp. Med. 213, 929–949 (2016).
doi: 10.1084/jem.20151437
Hanamsagar, R., Aldrich, A. & Kielian, T. Critical role for the AIM2 inflammasome during acute CNS bacterial infection. J. Neurochem. 129, 704–711 (2014).
doi: 10.1111/jnc.12669
Prinz, M., Erny, D. & Hagemeyer, N. Ontogeny and homeostasis of CNS myeloid cells. Nat. Immunol. 18, 385–392 (2017).
doi: 10.1038/ni.3703
Shinozaki, Y. et al. Transformation of astrocytes to a neuroprotective phenotype by microglia via P2Y1 receptor downregulation. Cell Rep. 19, 1151–1164 (2017).
doi: 10.1016/j.celrep.2017.04.047
Rothhammer, V. et al. Microglial control of astrocytes in response to microbial metabolites. Nature 557, 724–728 (2018).
doi: 10.1038/s41586-018-0119-x
Mao, L. et al. Pathogenic fungus Microsporum canis activates the NLRP3 inflammasome. Infect. Immun. 82, 882–892 (2014).
doi: 10.1128/IAI.01097-13
Goodridge, H. S. et al. Differential use of CARD9 by Dectin-1 in macrophages and dendritic cells. J. Immunol. 182, 1146–1154 (2009).
doi: 10.4049/jimmunol.182.2.1146
Weinblatt, M. E. et al. An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis. N. Engl. J. Med. 363, 1303–1312 (2010).
doi: 10.1056/NEJMoa1000500
Flynn, R. et al. Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease. Blood 125, 4085–4094 (2015).
doi: 10.1182/blood-2014-08-595470
Ruland, J., Duncan, G. S., Wakeham, A. & Mak, T. W. Differential requirement for Malt1 in T and B cell antigen receptor signaling. Immunity 19, 749–758 (2003).
doi: 10.1016/S1074-7613(03)00293-0
Tay, T. L. et al. A new fate mapping system reveals context-dependent random or clonal expansion of microglia. Nat. Neurosci. 20, 793–803 (2017).
doi: 10.1038/nn.4547
Goldmann, T. et al. A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation. Nat. Neurosci. 16, 1618–1626 (2013).
doi: 10.1038/nn.3531
Lionakis, M. S., Lim, J. K., Lee, C. C. R. & Murphy, P. M. Organ-specific innate immune responses in a mouse model of invasive candidiasis. J. Innate Immun. 3, 180–199 (2011).
doi: 10.1159/000321157
Cougnoux, A. et al. Microglia activation in Niemann–Pick disease, type C1 is amendable to therapeutic intervention. Hum. Mol. Genet. 27, 2076–2089 (2018).
doi: 10.1093/hmg/ddy112

Auteurs

Rebecca A Drummond (RA)

Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy & Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. r.drummond@bham.ac.uk.
Institute of Immunology & Immunotherapy, Institute of Microbiology & Infection, University of Birmingham, Birmingham, UK. r.drummond@bham.ac.uk.

Muthulekha Swamydas (M)

Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy & Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Vasileios Oikonomou (V)

Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy & Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Bing Zhai (B)

Infectious Disease Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

Ivy M Dambuza (IM)

Medical Research Council Centre for Medical Mycology at the University of Aberdeen, Aberdeen Fungal Group, Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK.

Brian C Schaefer (BC)

Department of Microbiology and Immunology, Uniformed Services University, Bethesda, MD, USA.

Andrea C Bohrer (AC)

Inflammation and Innate Immunity Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy & Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Katrin D Mayer-Barber (KD)

Inflammation and Innate Immunity Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy & Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Sergio A Lira (SA)

Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Yoichiro Iwakura (Y)

Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba, Japan.

Scott G Filler (SG)

Division of Infectious Diseases, Department of Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA, Torrance, CA, USA.

Gordon D Brown (GD)

Medical Research Council Centre for Medical Mycology at the University of Aberdeen, Aberdeen Fungal Group, Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK.

Bernhard Hube (B)

Department of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute Jena, Jena, Germany.
Friedrich Schiller University, Jena, Germany.

Julian R Naglik (JR)

Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London, UK.

Tobias M Hohl (TM)

Infectious Disease Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

Michail S Lionakis (MS)

Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy & Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. lionakism@niaid.nih.gov.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH